News of Note: Donanemab Gains FDA Approval for Early Alzheimer’s Treatment
Stephanie Collier, MD and Talia Puzantian, PharmD. Dr. Collier and Dr. Puzantian have no financial relationships with companies related to this material.
Dr. Collier is the director of education in the Division of Geriatric Psychiatry at McLean Hospital and an instructor in psychiatry at Harvard Medical School. Dr. Collier completed her psychiatry residency at Duke University Medical Center and fellowship in consultation-liaison psychiatry at Brigham and Women’s Hospital. Dr. Collier teaches and supervises medical students, residents, and fellows in geriatric psychiatry, and she works on projects training non-specialist clinicians in resource-limited settings.
Stephanie Collier, MD and Talia Puzantian, PharmD. Dr. Collier and Dr. Puzantian have no financial relationships with companies related to this material.
Stephanie Collier, MD. Dr. Collier has no financial relationships with companies related to this material.
Stephanie Collier, MD, MPH. Editor-in-Chief, Carlat Geriatric Psychiatry Report. Dr. Collier has no financial relationships with companies related to this material.
Stephanie Collier, MD, MPH, and Talia Puzantian, PharmD. Dr. Collier and Dr. Puzantian have no financial relationships with companies related to this material.
Clear, engaging, and practical updates on clinical psychiatry.
ViewClear, engaging, and practical updates on clinical psychiatry.
ViewPlease see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.
© 2024 Carlat Publishing, LLC and Affiliates, All Rights Reserved.